Precision medicine for asthma treatment: Unlocking the potential of the epigenome and microbiome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Precision medicine for asthma treatment: Unlocking the potential of the epigenome and microbiome

Published:2024-06 Issue: Volume: Page:
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Perez-Garcia Javier^ORCID,Cardenas Andres,Lorenzo-Diaz Fabian,Pino-Yanes Maria

Funder

CIBER

NIH Library

Publisher

Elsevier BV

Reference118 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019;Abbafati;Lancet,2020

2. Global strategy for asthma management and prevention,2023

3. Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States;Settipane;Ann Allergy Asthma Immunol,2019

4. Investigating asthma heterogeneity through shared and distinct genetics: insights from genome-wide cross-trait analysis;Zhu;J Allergy Clin Immunol,2021

5. Omics technologies in allergy and asthma research: an EAACI position paper;Radzikowska;Allergy,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP